Adherence and resource use among psoriasis patients treated with biologics.

Expert Rev Pharmacoecon Outcomes Res

a Center for Dermatology Research, Department of Dermatology , Wake Forest School of Medicine, Winston-Salem , NC , USA.

Published: December 2018

Introduction: The emergence of immune-modulating drugs such as biologics has altered the treatment landscape for psoriasis. However, their use presents high financial costs to patients and healthcare systems. Patient demographic and socioeconomic status may influence adherence to biologic medications and usage of healthcare resources.

Areas Covered: We performed a systematic literature review to summarize the available evidence pertaining to biologic medication adherence and resource use. PubMed was searched using the terms 'psoriasis and adherence' and 'psoriasis biologics resource use.'

Expert Commentary: Psoriasis patients utilize many healthcare resources. Adherence rates are typically higher for biologics than for other psoriasis treatment categories. However, adherence rates are still suboptimal.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737167.2018.1512408DOI Listing

Publication Analysis

Top Keywords

adherence resource
8
psoriasis patients
8
adherence rates
8
adherence
5
psoriasis
4
resource psoriasis
4
patients treated
4
biologics
4
treated biologics
4
biologics introduction
4

Similar Publications

Background and objective Hemophilia A (HA) is a genetic bleeding disorder caused by a lack of factor VIII (FVIII) and is associated with frequent bleeding and joint damage. Traditional intravenous treatments for this condition are cumbersome and can lead to complications. Emicizumab, a bispecific monoclonal antibody, offers a promising subcutaneous alternative with potential safety and efficacy-related benefits.

View Article and Find Full Text PDF

Background and objective Beta-blockers are a cornerstone in the management of acute coronary syndrome (ACS), effectively reducing myocardial oxygen demand, preventing recurrent ischemia, and lowering the risk of arrhythmias and reinfarction. Despite several established guidelines, such as those by the American College of Cardiology/American Heart Association (ACC/AHA), advocating their use within 24 hours for eligible patients, beta-blockers remain underutilized in clinical practice. This study aimed to analyze beta-blocker utilization patterns in ACS management and evaluate the impact of targeted improvement initiatives on their appropriate use in eligible ACS patients.

View Article and Find Full Text PDF

Multimedia learning theory suggests that the use of images in the classroom enhances both cognitive and constructive learning. Finding the appropriate images for medical presentations can be challenging due to copyright and privacy issues. Artificial intelligence (AI) image generation is a newly available technology that offers a great advantage to medical educators.

View Article and Find Full Text PDF

Background: An unhealthy diet is a major contributor to several noncommunicable diseases, including cardiovascular diseases (CVD), the leading cause of death worldwide. Additionally, our food system has significant impacts on the environment. The EAT-Lancet Commission has recommended a healthy diet that preserves global environmental resources.

View Article and Find Full Text PDF

Improving the health literacy of persons with epilepsy.

Epilepsy Behav

December 2024

Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address:

Improving health literacy can improve health. This essay reviews the resources available to help improve epilepsy health literacy, including websites, drug inserts/labels/information leaflets, patient educators, handouts, plain language, lay summaries, and other efforts to close the gaps between research and epilepsy health literacy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!